Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Rankning i aktier #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Aktiekurs
$0.14942078
Senast synkroniserad: 2025-05-15
Marknadsvärde
$3.86M
Förändring (1 dag)
0.10%
Förändring (1 år)
0.00%
Land
DE
Handel Medigene AG (MDG1)

Kategori

Historik för aktiesplit för Medigene AG (MDG1)
Aktien Medigene AG (symbol: MDG1) har genomgått totalt 2 aktiesplitar.
Den senaste spliten skedde den Aug 29, 2024.
En MDG1-aktie köpt före Sep 03, 2013 motsvarar nu 0.125 MDG1-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2024-08-29 1:2 x0.5 x0.125
2013-09-03 1:4 x0.25 x0.25
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE